bioAffinity Technologies Inc. has announced a new appointment within its management team. Maria Zannes, President and CEO of the company, has been selected to join the American Lung Association in Texas' Leadership Board. In this role, she will contribute to advancing lung health initiatives, focusing on early-stage lung cancer and other lung diseases. This appointment highlights the company's ongoing commitment to lung health research and advocacy.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.